MARATTO

article · International Immunopharmacology

Differences in leucocytes and inflammation-based indices among critically ill patients owing to SARS-CoV-2 variants during several successive waves of COVID-19 pandemic

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • COVID-19 Clinical Research Studies
  • Inflammatory Biomarkers in Disease Prognosis
  • Long-Term Effects of COVID-19

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.intimp.2023.110836

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.